Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Publisher Correction: Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment.

Shu S, Yang Y, Allen CL, Maguire O, Minderman H, Sen A, Ciesielski MJ, Collins KA, Bush PJ, Singh P, Wang X, Morgan M, Qu J, Bankert RB, Whiteside TL, Wu Y, Ernstoff MS.

Sci Rep. 2019 Mar 15;9(1):4959. doi: 10.1038/s41598-018-37179-1.

2.

KX2-361: a novel orally bioavailable small molecule dual Src/tubulin inhibitor that provides long term survival in a murine model of glioblastoma.

Ciesielski MJ, Bu Y, Munich SA, Teegarden P, Smolinski MP, Clements JL, Lau JYN, Hangauer DG, Fenstermaker RA.

J Neurooncol. 2018 Dec;140(3):519-527. doi: 10.1007/s11060-018-2992-4. Epub 2018 Sep 20.

PMID:
30238350
3.

Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment.

Shu S, Yang Y, Allen CL, Maguire O, Minderman H, Sen A, Ciesielski MJ, Collins KA, Bush PJ, Singh P, Wang X, Morgan M, Qu J, Bankert RB, Whiteside TL, Wu Y, Ernstoff MS.

Sci Rep. 2018 Aug 27;8(1):12905. doi: 10.1038/s41598-018-31323-7. Erratum in: Sci Rep. 2019 Mar 15;9(1):4959.

4.

Survivin Monoclonal Antibodies Detect Survivin Cell Surface Expression and Inhibit Tumor Growth In Vivo.

Fenstermaker RA, Figel SA, Qiu J, Barone TA, Dharma SS, Winograd EK, Galbo PM, Wiltsie LM, Ciesielski MJ.

Clin Cancer Res. 2018 Jun 1;24(11):2642-2652. doi: 10.1158/1078-0432.CCR-17-2778. Epub 2018 Mar 14.

5.

Circulating CD9+/GFAP+/survivin+ exosomes in malignant glioma patients following survivin vaccination.

Galbo PM Jr, Ciesielski MJ, Figel S, Maguire O, Qiu J, Wiltsie L, Minderman H, Fenstermaker RA.

Oncotarget. 2017 Oct 10;8(70):114722-114735. doi: 10.18632/oncotarget.21773. eCollection 2017 Dec 29.

6.

Novel vaccines for glioblastoma: clinical update and perspective.

Winograd EK, Ciesielski MJ, Fenstermaker RA.

Immunotherapy. 2016 Nov;8(11):1293-1308. Review.

7.

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.

Fenstermaker RA, Ciesielski MJ, Qiu J, Yang N, Frank CL, Lee KP, Mechtler LR, Belal A, Ahluwalia MS, Hutson AD.

Cancer Immunol Immunother. 2016 Nov;65(11):1339-1352. Epub 2016 Aug 30.

8.

Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6.

Andersson KM, Brisslert M, Cavallini NF, Svensson MN, Welin A, Erlandsson MC, Ciesielski MJ, Katona G, Bokarewa MI.

Oncotarget. 2015 Aug 21;6(24):20043-57.

9.

Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study.

Kusner LL, Ciesielski MJ, Marx A, Kaminski HJ, Fenstermaker RA.

PLoS One. 2014 Jul 22;9(7):e102231. doi: 10.1371/journal.pone.0102231. eCollection 2014.

10.

Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.

Fenstermaker RA, Ciesielski MJ.

Expert Rev Vaccines. 2014 Mar;13(3):377-85. doi: 10.1586/14760584.2014.881255. Review.

PMID:
24521310
11.

Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis.

Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA, Kovacic D, Slominski A, Kaetzel DM.

Cancer Res. 2012 Jan 1;72(1):133-43. doi: 10.1158/0008-5472.CAN-11-1795. Epub 2011 Nov 11.

12.

Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice.

Gil M, Bieniasz M, Seshadri M, Fisher D, Ciesielski MJ, Chen Y, Pandey RK, Kozbor D.

Br J Cancer. 2011 Nov 8;105(10):1512-21. doi: 10.1038/bjc.2011.429. Epub 2011 Oct 11.

13.

Antitumor cytotoxic T-cell response induced by a survivin peptide mimic.

Ciesielski MJ, Ahluwalia MS, Munich SA, Orton M, Barone T, Chanan-Khan A, Fenstermaker RA.

Cancer Immunol Immunother. 2010 Aug;59(8):1211-21. doi: 10.1007/s00262-010-0845-x. Epub 2010 Apr 27.

14.

Radiosensitization of GL261 glioma cells by tetraiodothyroacetic acid (tetrac).

Hercbergs A, Davis PJ, Davis FB, Ciesielski MJ, Leith JT.

Cell Cycle. 2009 Aug 15;8(16):2586-91. Epub 2009 Aug 22.

PMID:
19597333
15.

MRI-based characterization of vascular disruption by 5,6-dimethylxanthenone-acetic acid in gliomas.

Seshadri M, Ciesielski MJ.

J Cereb Blood Flow Metab. 2009 Aug;29(8):1373-82. doi: 10.1038/jcbfm.2009.68. Epub 2009 May 20.

16.

Expression of HMP/AN2, a melanoma associated antigen, in murine cerebral gliomas: potential for radioimmunotargeting.

Paul AK, Ciesielski MJ, Sajjad M, Wang X, Ferrone S, Abdel-Nabi H, Fenstermaker RA.

J Neurooncol. 2009 Aug;94(1):21-30. doi: 10.1007/s11060-009-9798-3. Epub 2009 Jan 20.

17.

EGFR Intron Recombination in Human Gliomas: Inappropriate Diversion of V(D)J Recombination?

Fenstermaker RA, Ciesielski MJ.

Curr Genomics. 2007 May;8(3):163-70.

18.

Therapeutic effect of a T helper cell supported CTL response induced by a survivin peptide vaccine against murine cerebral glioma.

Ciesielski MJ, Kozbor D, Castanaro CA, Barone TA, Fenstermaker RA.

Cancer Immunol Immunother. 2008 Dec;57(12):1827-35. doi: 10.1007/s00262-008-0510-9. Epub 2008 Apr 26.

19.

Molecular targeting and treatment of composite EGFR and EGFRvIII-positive gliomas using boronated monoclonal antibodies.

Yang W, Wu G, Barth RF, Swindall MR, Bandyopadhyaya AK, Tjarks W, Tordoff K, Moeschberger M, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2008 Feb 1;14(3):883-91. doi: 10.1158/1078-0432.CCR-07-1968.

20.

Molecular targeting and treatment of an epidermal growth factor receptor-positive glioma using boronated cetuximab.

Wu G, Yang W, Barth RF, Kawabata S, Swindall M, Bandyopadhyaya AK, Tjarks W, Khorsandi B, Blue TE, Ferketich AK, Yang M, Christoforidis GA, Sferra TJ, Binns PJ, Riley KJ, Ciesielski MJ, Fenstermaker RA.

Clin Cancer Res. 2007 Feb 15;13(4):1260-8.

21.

Cell-surface receptor for thyroid hormone and tumor cell proliferation.

Davis PJ, Davis FB, Lin HY, Bergh JJ, Mousa S, Hercbergs A, Fenstermaker RA, Ciesielski MJ.

Expert Rev Endocrinol Metab. 2006 Nov;1(6):753-761. doi: 10.1586/17446651.1.6.753.

PMID:
30754150
22.

Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ.

Clin Cancer Res. 2006 Jun 15;12(12):3792-802.

23.

Antitumor effects of a xenogeneic survivin bone marrow derived dendritic cell vaccine against murine GL261 gliomas.

Ciesielski MJ, Apfel L, Barone TA, Castro CA, Weiss TC, Fenstermaker RA.

Cancer Immunol Immunother. 2006 Dec;55(12):1491-503. Epub 2006 Feb 17.

PMID:
16485128
24.

Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4.

Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ.

Clin Cancer Res. 2005 Jan 1;11(1):341-50.

25.

Cellular antitumor immune response to a branched lysine multiple antigenic peptide containing epitopes of a common tumor-specific antigen in a rat glioma model.

Ciesielski MJ, Kazim AL, Barth RF, Fenstermaker RA.

Cancer Immunol Immunother. 2005 Feb;54(2):107-19. Epub 2004 Aug 31.

PMID:
15340764
26.

2-Methoxyestradiol inhibits proliferation of normal and neoplastic glial cells, and induces cell death, in vitro.

Lis A, Ciesielski MJ, Barone TA, Scott BE, Fenstermaker RA, Plunkett RJ.

Cancer Lett. 2004 Sep 15;213(1):57-65.

PMID:
15312684
27.

Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas.

Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):981-5.

PMID:
15308179
28.

Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent.

Barth RF, Wu G, Yang W, Binns PJ, Riley KJ, Patel H, Coderre JA, Tjarks W, Bandyopadhyaya AK, Thirumamagal BT, Ciesielski MJ, Fenstermaker RA.

Appl Radiat Isot. 2004 Nov;61(5):899-903.

PMID:
15308165
29.

Immunotherapeutic strategies for malignant glioma.

Fenstermaker RA, Ciesielski MJ.

Cancer Control. 2004 May-Jun;11(3):181-91. Review.

PMID:
15153842
30.
31.

Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas.

Yang W, Barth RF, Adams DM, Ciesielski MJ, Fenstermaker RA, Shukla S, Tjarks W, Caligiuri MA.

Cancer Res. 2002 Nov 15;62(22):6552-8.

32.

2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.

Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA, Dougherty TJ.

Lasers Surg Med. 2001;29(5):397-405.

PMID:
11891727
33.
34.
36.

Intratumoral infusion of topotecan prolongs survival in the nude rat intracranial U87 human glioma model.

Pollina J, Plunkett RJ, Ciesielski MJ, Lis A, Barone TA, Greenberg SJ, Fenstermaker RA.

J Neurooncol. 1998 Sep;39(3):217-25.

PMID:
9821107
37.

Supplemental Content

Loading ...
Support Center